Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Jul 2011 09:12 AM
RNS
Holding(s) in Company
28 Jun 2011 07:00 AM
RNS
Notice of Results
07 Jun 2011 07:00 AM
RNS
Research Agreement with ImaginAb
26 May 2011 07:00 AM
RNS
Block Listing Six Monthly Return
24 May 2011 07:00 AM
RNS
Management and Board Changes
23 May 2011 07:00 AM
RNS
NEW CLINICAL DATA FROM PROSAVIN? PHASE I/II STUDY
19 May 2011 04:40 PM
RNS
Second Price Monitoring Extn
19 May 2011 04:35 PM
RNS
Price Monitoring Extension
18 May 2011 07:00 AM
RNS
Interim Management Statement
05 May 2011 12:54 PM
RNS
Annual General Meeting and Board Changes
04 May 2011 07:00 AM
RNS
Pfizer License Extension
03 May 2011 07:00 AM
RNS
Announcement of Data in ProSavin Study
15 Apr 2011 01:04 PM
RNS
Directors' Interest in Shares and Share Options
14 Apr 2011 04:40 PM
RNS
Second Price Monitoring Extn
14 Apr 2011 04:35 PM
RNS
Price Monitoring Extension
04 Apr 2011 10:28 AM
RNS
Annual Information Update
31 Mar 2011 07:12 AM
RNS
Annual Report and Accounts & AGM Notification
22 Mar 2011 07:00 AM
RNS
Director/PDMR Shareholding
21 Mar 2011 07:01 AM
RNS
Directorate Change
21 Mar 2011 07:00 AM
RNS
StarGen US IND Approval
02 Mar 2011 07:00 AM
RNS
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2010
09 Feb 2011 07:00 AM
RNS
Appointment of Head of Manufa
31 Jan 2011 04:40 PM
RNS
Second Price Monitoring Extn
31 Jan 2011 04:35 PM
RNS
Price Monitoring Extension
31 Jan 2011 12:20 PM
RNS
Total Voting Rights Update
31 Jan 2011 12:19 PM
RNS
Notification of Major Interes
31 Jan 2011 07:00 AM
RNS
Acquisition of Manufacturing
20 Jan 2011 07:00 AM
RNS
Notice of Preliminary Results
12 Jan 2011 08:20 AM
RNS
Holding in Company
10 Jan 2011 08:47 AM
RNS
Directors' Interest in Shares
07 Jan 2011 11:30 AM
RNS
Result of General Meeting
07 Jan 2011 07:00 AM
RNS
Result of Open Offer
23 Dec 2010 12:00 PM
RNS
Presentation at J.P. Morgan H
22 Dec 2010 07:00 AM
RNS
ProSavin Phase I/II Update
14 Dec 2010 07:22 AM
RNS
Publication of Prospectus
13 Dec 2010 04:50 PM
RNS
Re Proposed Fundraising
13 Dec 2010 07:47 AM
RNS
Proposed Fundraising
26 Nov 2010 07:00 AM
RNS
BLOCK LISTING SIX MONTHLY RET
09 Nov 2010 07:00 AM
RNS
US IND APPROVAL FOR RETINOSTA
29 Oct 2010 07:00 AM
RNS
Oxford Biomedica PLC Interim
26 Oct 2010 04:35 PM
RNS
Price Monitoring Extension
14 Oct 2010 07:00 AM
RNS
Publication in Clinical Cance
14 Oct 2010 07:00 AM
RNS
Change of Adviser and Broker
22 Sep 2010 07:00 AM
RNS
TROVAX® SELECTED AS ONE OF TO
15 Sep 2010 11:53 AM
RNS
Holding(s) in Company
24 Aug 2010 07:00 AM
RNS
Half Yearly Report
18 Aug 2010 10:31 AM
RNS
Holding(s) in Company
18 Aug 2010 07:00 AM
RNS
Emergent Licensing Agreement
26 Jul 2010 07:00 AM
RNS
TroVax Update
01 Jul 2010 07:00 AM
RNS
OXB awarded research grant

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings